Home
News
Create
Screeners
Insights
Dipna Pharmachem
13.
50
+1.60
(+13.45%)
Market Cap
₹35.51 Cr
PE Ratio
32.16
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+13.45%
1M
-18.63%
6M
-40.92%
1Y
-10.00%
5Y
-50.80%
View Company Insights
Latest news about Dipna Pharmachem
Dipna Pharmachem Limited Receives BSE Trading Approval for 22.44 Lakh Equity Shares from Warrant Conversion
8 days ago
Dipna Pharmachem Limited received BSE trading approval for 22,44,000 equity shares issued through warrant conversion on preferential basis, effective January 20, 2026. The shares, priced at ₹13.05 each (₹10.00 face value plus ₹3.05 premium), were allotted to non-promoters with total value of approximately ₹29.27 crores. The approval process began with warrant application in March 2025 and culminated with trading commencement following proper regulatory compliance under SEBI regulations.
Dipna Pharmachem Responds to BSE Inquiry on Stock Price Movement, Cites Market-Driven Volatility
8 days ago
Dipna Pharmachem Reports 319% Surge in Net Profit for H1 FY2026, Raises Funds Through Convertible Warrants
Nov 26, 2025
Dipna Pharmachem Allots 2.99 Crore Convertible Warrants at Rs 13.05 Each on Preferential Basis
Sep 09, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation